Table 2.
Prevalence of co-morbidities among patients with and without neurological symptoms.
|
Variables |
Neurological symptoms during COVID-19 disease |
Missing patients | P-Value | OR |
95% confidence interval |
|||
|---|---|---|---|---|---|---|---|---|
| Title | Status | Shown [N, (%)] | Not-shown [N, (%)] | Lower | Upper | |||
| Diabetes | Yes | 89,(11.6) | 9,(12.9) | 5 | 0.846 | 0.892 | 0.428 | 1.859 |
| No | 676,(88.4) | 61,(87.1) | 51 | |||||
| Hypertension | Yes | 121,(15.8) | 9,(12.9) | 7 | 0.607 | 1.273 | 0.616 | 2.633 |
| No | 644,(84.2) | 61,(87.1) | 49 | |||||
| Heart diseasea | Yes | 69,(9.0) | 6,(8.6) | 1 | 1.000 | 1.057 | 0.442 | 2.531 |
| No | 696,(91.0) | 64,(91.4) | 55 | |||||
| Respiratory diseaseb | Yes | 68,(8.9) | 4,(5.7) | 2 | 0.394 | 1.610 | 0.569 | 4.552 |
| No | 697,(91.1) | 66,(94.3) | 54 | |||||
| Autoimmune and rheumatologic diseasec | Yes | 35,(4.6) | 3,(4.3) | 0 | 1.000 | 1.071 | 0.321 | 3.574 |
| No | 730,(95.4) | 67,(95.7) | 56 | |||||
| Any pre-existing neurological conditiond | Yes | 104,(13.6) | 1,(1.4) | 3 | 0.004 | 10.906 | 1.498 | 79.377 |
| No | 660,(86.4) | 70,(98.6) | 53 | |||||
| Migraine and other primary headaches | Yes | 159,(20.8) | 5,(7.1) | 3 | 0.007 | 3.411 | 1.351 | 8.612 |
| No | 606,(79.2) | 65,(92.2) | 53 | |||||
| Epilepsy | Yes | 11,(1.4) | 0,(0) | 0 | 0.613 | - | - | |
| No | 754,(98.6) | 70,(100) | 56 | |||||
| Stroke | Yes | 17,(2.2) | 0,(0) | 0 | 0.387 | - | - | |
| No | 748,(97.8) | 70,(100) | 56 | |||||
| Multiple sclerosis | Yes | 6,(0.8) | 0,(0) | 1 | 0.674 | - | - | |
| No | 759,(99.2) | 70,(100) | 55 | |||||
a
Congestive heart failure (CHF), old myocardial infarction (MI), coronary artery disease (CAD), unstable angina (UA) and arrhythmia.
b
Asthma, chronic obstructive pulmonary disease(COPD), chronic lung diseases, sinusitis.
c
Systemic lupus erythematosus, rheumatoid arthritis(RA), behcet’s disease, sjogren’s syndrome.
d
Any primary chronic headache, stroke, epilepsy, multiple sclerosis (MS), Parkinson’s disease, Alzheimer disease, meningitis, myasthenia gravis and any other confirmed neurological disorder.